Faculty alterations of patient treatment plans

1989 ◽  
Vol 53 (10) ◽  
pp. 587-589
Author(s):  
S Kennon
Keyword(s):  
Patient Treatment ◽  
Treatment Plans

scholarly journals Perceptions of Treatment Burden Among Elders With Diabetes and Comorbid Alzheimer’s Disease and Related Dementias

2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 276-276
Author(s):  
Victoria Vaughan Dickson ◽  
Halia Melnyk ◽  
Rosie Ferris ◽  
Joshua Chodosh ◽  
Caroline Blaum
Keyword(s):  
Alzheimer’S Disease ◽  
Older Adults ◽  
Alzheimer's Disease ◽  
Qualitative Study ◽  
Financial Burden ◽  
Controlled Trial ◽  
Healthcare Providers ◽  
Patient Treatment ◽  
Treatment Burden ◽  
Treatment Plans

Abstract Background: An estimated 25% of older adults with diabetes (DM) may have co-occurring Alzheimer’s Disease and Related Dementias (ADRD), complicated by multiple treatment plans and providers. Assessing treatment burden has been limited to patients’ perspectives; little is known about caregiver perceptions of treatment burden despite their important role in personal care and treatment adherence. The purpose of this qualitative study was to describe caregiver perceptions of treatment burden for older adults with DM-ADRD. Methods: This qualitative study was conducted in the formative phase of “Enhanced Quality in Primary care for Elders with DM-ADRD (EQUIPED-ADRD) a pragmatic randomized controlled trial in a large, diverse healthcare system. A diverse sample of caregivers (n=15) of patients enrolled in the RCT participated in interviews about their caregiver role and perceptions of treatment burden of DM-ADRD clinical management. Qualitative data were analyzed using content analysis and themes about treatment burden were compared to domains on the Treatment Burden Questionnaire (TBQ). Results: Caregivers reported high levels of burden related to treatment plans for patients with DM-ADRD. Themes related to complexity and burden of medication management, monitoring (e.g., blood pressure, glucose monitoring), dietary and physical activity regimens, navigating healthcare providers and financial burden were reported. Caregivers also described high levels of emotional burden that was associated with patient’s cognitive decline and family functioning stress. Conclusions: Interventions to reduce treatment burden for patients and caregiver should include activating social/nursing services, respite care and care coordination that may support caregivers especially as patient treatment increases in complexity over time.

Assessing HIPAA Compliance of Open Source Electronic Health Record Applications

2021 ◽  
Vol 15 (2) ◽  
pp. 181-195
Author(s):  
Hossain Shahriar ◽  
Hisham M. Haddad ◽  
Maryam Farhadi
Keyword(s):  
Electronic Health Record ◽  
Open Source ◽  
Medical Decision ◽  
Patient Treatment ◽  
Health Record ◽  
Technical Requirements ◽  
Patient Health ◽  
Treatment Plans ◽  
Electronic Health ◽  
Quality In Healthcare

Electronic health record (EHR) applications are digital versions of paper-based patient health information. EHR applications are increasingly being adopted in many countries. They have resulted in improved quality in healthcare, convenient access to histories of patient medication and clinic visits, easier follow up of patient treatment plans, and precise medical decision-making process. The goal of this paper is to identify HIPAA technical requirements, evaluate two open source EHR applications (OpenEMR and OpenClinic) for security vulnerabilities using two open-source scanner tools (RIPS and PHP VulnHunter), and map the identified vulnerabilities to HIPAA technical requirements.

SU-GG-J-52: Inclusion of KV CBCT Dose in the Patient Treatment Plans and Evaluation of Dose to Normal Tissue and Critical Organs

2010 ◽  
Vol 37 (6Part10) ◽  
pp. 3157-3157
Author(s):  
P Alaei ◽  
E Spezi ◽  
P Downes ◽  
R Jarvis ◽  
E Radu ◽  
...  
Keyword(s):  
Normal Tissue ◽  
Patient Treatment ◽  
Treatment Plans

scholarly journals An analysis on medical expenses of multidisciplinary cancer care under health insurance

2021 ◽  
Vol 64 (10) ◽  
pp. 711-716
Author(s):  
Myungjin Jung ◽  
Byungyul Jun
Keyword(s):  
Health Insurance ◽  
Cancer Patients ◽  
Cancer Care ◽  
Treatment Plan ◽  
Multidisciplinary Care ◽  
Therapeutic Modality ◽  
Patient Treatment ◽  
Medical Expenses ◽  
Hospitalization Costs ◽  
Treatment Plans

Background: Cancer has been the leading cause of death in Korea for more than 40 years. As the aging population in the country increases, this trend is expected to continue. Cancer care is also being subdivided into specialties according to the development of medical technology. This division of care has made it difficult for a single physician to set up a complete cancer treatment plan. As a result, the call for multidisciplinary care has risen. Multidisciplinary cancer care allows physicians to share opinions and choose optimal patient treatment plans across multiple specialties. In August 2014, the Ministry of Health and Welfare designated a set number of approved multidisciplinary treatments and has included them under its health insurance coverage. As a result, multidisciplinary care is rapidly increasing.Current Concepts: An analysis on cancer care was conducted from 2014 to 2018, which examined the average medical expenses, hospitalization costs, and surgery costs per person according to therapeutic modality. Findings showed that multidisciplinary care decreased the overall cost of medical care in cancer patients compared to segmented care provided by single specialty physicians.Discussion and Conclusion: This study predicted that multidisciplinary care would be effective in reducing medical expenses. Cancer patients do not need to be treated by individual subspecialty physicians when personalized care treatment plans through a multidisciplinary approach is possible. The results of this study show that the Korean government should expand health insurance premium support and coverage for multidisciplinary cancer care.

TH-E-BRCD-02: Automated Treatment Planning Using a Database of Prior Patient Treatment Plans

2012 ◽  
Vol 39 (6Part30) ◽  
pp. 4008-4008 ◽  
Author(s):  
T McNutt ◽  
B Wu ◽  
J Moore ◽  
S. Petit ◽  
M. Kazhdan ◽  
...  
Keyword(s):  
Treatment Planning ◽  
Patient Treatment ◽  
Treatment Plans

scholarly journals Traditional & narrative practices of treatment for depression and depressive symptoms in older adults

2022 ◽  
Vol 9 (1) ◽  
pp. 14-15
Author(s):  
Courtni Jeffers
Keyword(s):  
Older Adults ◽  
Depressive Symptoms ◽  
Organizational Climate ◽  
Organizational Context ◽  
Treatment Guidelines ◽  
Positive Impact ◽  
Treatment Plan ◽  
Patient Treatment ◽  
Treatment Plans ◽  
Self Discovery

An analysis and evaluation of the literature regarding traditional treatment methods for depression among older adults compared the effectiveness of the results to the benefits of a treatment plan that integrates the narrative practices of storytelling and reflexive writing. Priority was given to peer-reviewed journal articles from 2008 forward, though some earlier information was used for clarification and foundation building. The formation and implementation of individual patient treatment plans for depression and depressive symptoms are impacted by many variables such as: Confusion surrounding provider treatment guidelines, social organizational context, organizational climate and the differing definitions of depression that exist among providers and patients. Patients often struggle to self-identify or put words to depressive symptoms and the process of reflexive writing is transformative and increases narrative competency, which strengthens a patient’s ability to give an account of oneself, aiding in self-discovery and personal symptom awareness. An imbalance of power exists in the clinical encounter and the practices and principles of the discipline of Narrative Medicine can have a positive impact on strengthening the therapeutic alliance and treatment outcomes. Older adults with depression and depressive symptoms have a lower quality of life and often feel less productive in their communities. Traditional pharmacologically based depression treatment plans are one-dimensional and often fail to address personal patient context and preference. Older adults living with diagnosed depression and depressive symptoms can be better served with treatment plans that include narrative techniques that increase alliance, affiliation, self-awareness and self-discovery.  

Using the ICF to develop patient treatment plans and to promote interdisciplinary teamwork

2009 ◽  
Vol 2 (1) ◽  
pp. e1
Author(s):  
David Hollar ◽  
Cherri Hobgood ◽  
Ellen Roberts ◽  
Susan Sawning ◽  
Donald Woodyard ◽  
...  
Keyword(s):  
Patient Treatment ◽  
Interdisciplinary Teamwork ◽  
Treatment Plans

scholarly journals Brainstem NTCP and Dose Constraints for Carbon Ion RT—Application and Translation From Japanese to European RBE-Weighted Dose

2020 ◽  
Vol 10 ◽  
Author(s):  
Jon Espen Dale ◽  
Silvia Molinelli ◽  
Barbara Vischioni ◽  
Viviana Vitolo ◽  
Maria Bonora ◽  
...  
Keyword(s):  
Absorbed Dose ◽  
Normal Tissue Complication Probability ◽  
Local Effect ◽  
Patient Treatment ◽  
Carbon Ion ◽  
Applied Dose ◽  
Dose Metrics ◽  
Treatment Plans ◽  
Dose Constraints ◽  
The Relationship

Background and PurposeThe Italian National Center of Oncological Hadrontherapy (CNAO) has applied dose constraints for carbon ion RT (CIRT) as defined by Japan’s National Institute of Radiological Sciences (NIRS). However, these institutions use different models to predict the relative biological effectiveness (RBE). CNAO applies the Local Effect Model I (LEM I), which in most clinical situations predicts higher RBE than NIRS’s Microdosimetric Kinetic Model (MKM). Equal constraints therefore become more restrictive at CNAO. Tolerance doses for the brainstem have not been validated for LEM I-weighted dose (DLEM I). However, brainstem constraints and a Normal Tissue Complication Probability (NTCP) model were recently reported for MKM-weighted dose (DMKM), showing that a constraint relaxation to DMKM|0.7 cm3 <30 Gy (RBE) and DMKM|0.1 cm3 <40 Gy (RBE) was feasible. The aim of this work was to evaluate the brainstem NTCP associated with CNAO’s current clinical practice and to propose new brainstem constraints for LEM I-optimized CIRT at CNAO.Material and MethodsWe reproduced the absorbed dose of 30 representative patient treatment plans from CNAO. Subsequently, we calculated both DLEM I and DMKM, and the relationship between DMKM and DLEM I for various brainstem dose metrics was analyzed. Furthermore, the NTCP model developed for DMKM was applied to estimate the NTCPs of the delivered plans.ResultsThe translation of CNAO treatment plans to DMKM confirmed that the former CNAO constraints were conservative compared with DMKM constraints. Estimated NTCPs were 0% for all but one case, in which the NTCP was 2%. The relationship DMKM/DLEM I could be described by a quadratic regression model which revealed that the validated DMKM constraints corresponded to DLEM I|0.7 cm3 <41 Gy (RBE) (95% CI, 38–44 Gy (RBE)) and DLEM I|0.1 cm3 <49 Gy (RBE) (95% CI, 46–52 Gy (RBE)).ConclusionOur study demonstrates that RBE-weighted dose translation is of crucial importance in order to exchange experience and thus harmonize CIRT treatments globally. To mitigate uncertainties involved, we propose to use the lower bound of the 95% CI of the translation estimates, i.e., DLEM I|0.7 cm3 <38 Gy (RBE) and DLEM I|0.1 cm3 <46 Gy (RBE) as brainstem dose constraints for 16 fraction CIRT treatments optimized with LEM I.

scholarly journals STUDI TINGKAT PENGETAHUAN DAN PERSEPSI TENAGA KESEHATAN MENGENAI PERANAN FARMAKOGENOMIK

2021 ◽  
Vol 6 (2) ◽  
pp. 161-167
Author(s):  
Muhammad Akib Yuswar ◽  
◽  
Robiyanto Robiyanto ◽  
Eka Kartika Untari ◽  
Shoma Rizkifani ◽  
...  
Keyword(s):  
Primary Data ◽  
Patient Treatment ◽  
Survey Method ◽  
Online Questionnaire ◽  
West Kalimantan ◽  
Health Practitioners ◽  
Treatment Plans ◽  
Negative Perceptions ◽  
Level Of Knowledge

Research on the extent to which health practitioners in West Kalimantan understand the important role of pharmacogenomics have not been reported to date. West Kalimantan (Kalbar) is known as a province characterized by three main ethnicities, namely Chinese, Malay and Dayak. Therefore, the potential application of pharmacogenomics for the treatment of patients in health facilities across the province is very possible. This study aimed to measure the level of knowledge and perceptions of health practitioners (participants) about the role of pharmacogenomics in patient treatment plans. This research is descriptive with a questionnaire-based survey method. The data analyzed is primary data from the answers of participants to the online questionnaire. Based on the responses of 106 participants (involving doctors, pharmacists, nurses, midwives, and others) from various cities and districts in West Kalimantan, it was found that the level of knowledge was very good (75.5%), good (17.0%), and not good. (7.5%). The level of participants' perceptions of the role of pharmacogenomics are those who have positive perceptions (97.2%) and negative perceptions (2.8%). It can be concluded that 75% of health practitioners in West Kalimantan have a very good level of knowledge and 97% of them own a positive perception of the importance of pharmacogenomics.

Sign in / Sign up

Export Citation Format

Share Document